Publications & Presentations

Journal Publications

Amoruccio VJ, Mital DP, Srinivasan S. A Risk Score to Evaluate the Risk of Lung Cancer in People with HIV. Journal of Cancer Clinical Trials. Volume 6:3, 2021. (PDF)

Dolan SM, Gross SJ, Merkatz IR, Faber V*, Sullivan LM, Malone FD, Porter TF, Nyberg DA, Comstock CH, Hankins GD, Eddleman K, Dugoff L, Craigo SD, Timor-Tritsch I, Carr SR, Wolfe HM, Bianchi DW, D'Alton ME. The contribution of birth defects to preterm birth and low birth weight. Obstet Gynecol. 2007 Aug;110(2 Pt 1):318-24. doi: 10.1097/01.AOG.0000275264.78506.63. PMID: 17666606.

Paasche-Orlow MK, Cheng DM, Palepu A, Meli S, Faber V*, Samet JH. Health literacy, antiretroviral adherence, and HIV-RNA suppression: a longitudinal perspective. J Gen Intern Med. 2006 Aug;21(8):835-40. doi: 10.1111/j.1525-1497.2006.00527.x. PMID: 16881943; PMCID: PMC1831568.

Dugoff, L; Hobbins, J; Faber, V*; Malone, F; Belfort, M; Nyberg, D; Comstock, C; Bukowski, R; Eddleman, K; Gross, S; Craigo, S; Timor, I; Carr, S; Wolfe, H; D'alton, M. “First trimester uterine artery Doppler and subsequent intrauterine growth restriction and preterm birth”; American Journal of Obstetrics and Gynecology (OB); December 2004, Supplement • Volume 191 • Number 6 • pS22 to pS22

Dugoff, L; Faber, V*; Hobbins, J; Malone, F; Canick, J; Porter, F; Luthy, D; Comstock, C; Bukowski, R; Eddleman, K; Gross, S; Craigo, S; Timor-Trisch, I; Carr, S; Wolfe, H; D'alton, M; “The effect of vaginal bleeding on maternal serum PAPP-A, free [beta] -hCG, and nuchal translucency. A population based screening study (the FASTER trial)”; American Journal of Obstetrics and Gynecology (OB); December 2004, Supplement • Volume 191 • Number 6 • pS47 to pS47

*Published as Vincent Faber aka Vincent Amoruccio

Conference Presentations

PharmaSUG: A TransCelerate Initiative – How Can You Modernize Your Statistical Environment? (May 2021)

SCOPE Summit: Statistical Programming Demystified (February 2016) – Invited Speaker for CHI’s Clinical Research Statistics for Non-statisticians.

Semi-Annual Clinical Affairs and Regulatory Approvals for Diagnostics Conference: Staying Abreast of Updated Clinical Data Management Standards (October 2015) – Q1 Productions – Invited Speaker.

SCOPE Summit: Doing More, Faster, Better! How CDISC Data Standards Shorten the Clinical Trial Life Cycle Across the Globe (February 2015) – Invited Speaker for CHI’s Electronic Data in Clinical Trials Conference.

Clinical Data Standards & Transparency Conference: Going Global – How Data Standards Can Improve the Management of Trial Data Across Borders (July 2014) – Invited Speaker for CBI Net.

Pharmaceutical SAS User Group (PharmaSUG) Conference: The New Tradition: SAS® Clinical Data Integration (June 2014) – Applications Development Section.

North East SAS Users Group (NESUG) Conference: Using SAS® Metadata as a Key Performance Indicator (September 2013) – Invited Speaker for Management and Administration Section. Also, presented as an invited speaker at Clinical Data Analytics (July 2013).

Pharmaceutical SAS User Group (PharmaSUG) Conference: The Y2K17 Bug! Responding to PDUFA Requirements through a Metadata System (May 2013) – Data Standards Section.

Pharmaceutical SAS User Group (PharmaSUG) 2012 Conference: Could Have, Would Have, Should Have! Adopting Good Programming Standards, Not Practices, to Survive an Audit! (May 2012) – Best Paper for Industry Basics Section. Also, presented at Denver SAS User Group (October 2012).

SAS User Group 30: Using Procedure-Based ODS Data Components in Statistical Reporting (March 2005. Also, presented at Pharmaceutical SAS User Group 25 (June 2005)